Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1694-1702
Published online before print July 31, 2008, doi: 10.1161/ATVBAHA.107.155143
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/10/1694    most recent
ATVBAHA.107.155143v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kavurma, M. M.
Right arrow Articles by Bennett, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kavurma, M. M.
Right arrow Articles by Bennett, M. R.
Related Collections
Right arrow Apoptosis
Right arrow Cell signalling/signal transduction
Right arrow Smooth muscle proliferation and differentiation
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1694.)
© 2008 American Heart Association, Inc.


Brief Reviews

Death Receptors and Their Ligands in Atherosclerosis

Mary M. Kavurma; Nicole Y. Tan; Martin R. Bennett

From the Centre for Vascular Research (M.M.K., N.Y.T.), The University of New South Wales, Australia; and the Division of Cardiovascular Medicine (M.R.B.), University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK.

Correspondence to Dr Mary M. Kavurma, The Centre for Vascular Research, The University of New South Wales, Sydney NSW 2052, Australia. E-mail m.kavurma{at}unsw.edu.au

Atherosclerosis is characterized by the accumulation of a fibro-fatty plaque consisting of immune cells, vascular smooth muscle cells (VSMCs), vascular endothelial cells (ECs), and extracellular matrix, surrounding a lipid-rich core. The complexity of atherosclerosis is highlighted by the multifaceted effects that apoptosis and proliferation of specific cell types can have on vessels at different stages of the disease. Death receptors are membrane-bound protein complexes that on binding their cognate ligand, activate an intracellular signaling cascade that results in apoptosis. More recently, signaling from these receptors has been shown to activate multiple other processes, including cell proliferation. This review summarizes our current understanding of signaling events after death receptor activation and the role of death receptors and their ligands in atherosclerosis.

On binding to their ligands, death receptors transmit apoptotic signals leading to irreversible programmed cell death. Recent studies also implicate death receptors in survival/activation signals, and consequently their role in atherosclerosis is unclear. This review encapsulates our recent understanding of death receptor signaling in atherosclerosis and related disorders.


Key Words: apoptosis • TNF/TNFR signalling • proliferation • atherosclerosis




This article has been cited by other articles:


Home page
EndocrinologyHome page
N. Pamir, T. S. McMillen, K. J. Kaiyala, M. W. Schwartz, and R. C. LeBoeuf
Receptors for Tumor Necrosis Factor-{alpha} Play a Protective Role against Obesity and Alter Adipose Tissue Macrophage Status
Endocrinology, September 1, 2009; 150(9): 4124 - 4134.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Y. Tan, J.-M. Li, R. Stocker, and L. M. Khachigian
Angiotensin II-Inducible Smooth Muscle Cell Apoptosis Involves the Angiotensin II Type 2 Receptor, GATA-6 Activation, and FasL-Fas Engagement
Circ. Res., August 28, 2009; 105(5): 422 - 430.
[Abstract] [Full Text] [PDF]